ArticleActa dermato-venereologica2024

Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors.

Chul Hwan Bang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.